Am Heart J

1. KIM S, Bertolet M, Chaitman BR, Alexander JH, et al
   Recurrent myocardial infarction identified by centralized troponin review: Insights from the MINT trial.
   Am Heart J. 2026 Aug 9:107553. doi: 10.1016/j.ahj.2026.107553.
   

   >> Share

   
   

   
   Am J Cardiol

2. TIOH JK, Tsutsumi T, Mori K, Takahashi H, et al
   Performance of Cardiovascular Risk Equations for Cardiovascular Mortality Prediction in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease.
   Am J Cardiol. 2026 Aug 14:S0002-9149(26)00520.
   

   >> Share

   
   
3. KALABA F, Garg Y, Odukwe C, Oliva A, et al
   Incidence, Predictors, and Clinical Impact of Early Readmission After Complex Percutaneous Coronary Intervention.
   Am J Cardiol. 2026 Aug 14:S0002-9149(26)00521.
   

   >> Share

   
   

   
   Angiology

4. KILIC O, Yalcinkaya Oner D, Karacali K, Mustu M, et al
   Association of the C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index With In-Hospital Mortality Among Elderly Patients Admitted for Acute Coronary Syndrome.
   Angiology. 2026 Aug 11:33197261476789. doi: 10.1177/00033197261476789.
   

   >> Share

   
   

   
   Ann Intern Med

5. LIBMAN H, O'Glasser AY, Fleischmann KE, Kanjee Z, et al
   How Would You Manage Perioperative Cardiovascular Risk for Noncardiac Surgery in This Patient With Complex Comorbidity? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
   Ann Intern Med. 2026 Aug 11. doi: 10.7326/ANNALS-26-02584.
   

   >> Share

   
   

   
   Br J Haematol

6. MOHAMMED A, Galadanci NA, Hellemann G, Kanter J, et al
   Evaluating high-sensitivity troponin levels in people with sickle cell disease in the emergency department.
   Br J Haematol. 2026;209:833-836.
   

   >> Share

   
   

   
   Chest

7. YI L, Yao H
   Methodologic Flaws in the Study of Pulse Wave Amplitude Drop and Cardiovascular Risk.
   Chest. 2026;170:e66-e67.
   

   >> Share

   
   
8. LIU Z, Hu C, Jiang M
   Competing Risks in COPD: Do High Non-Cardiovascular Mortality Rates Overestimate Absolute Major Adverse Cardiovascular Event Risk?
   Chest. 2026;170:e60.
   

   >> Share

   
   
9. 
   Corrigendum to: de-Torres JP, Casanova C, Zagaceta J, et al. Cardiovascular Events in COPD: Complementary Role of Cardiac Risk and Coronary Artery Calcium Scores. CHEST. 2026;169(3):631-640.
   Chest. 2026;170:632.
   

   >> Share

   
   
10. CHANDRA D
    Not All Emphysema Is Equal: Centrilobular Subtype as a Window Into Cardiovascular Risk.
    Chest. 2026;170:287-289.
    

    >> Share

    
    

    
    Circ Heart Fail

11. ADEL FW, Gochanour B, Scott C, Singh J, et al
    Elevated Endogenous Insulin and Insulin Resistance Are Associated With Progressive Diastolic Dysfunction and Worse Cardiovascular Outcomes.
    Circ Heart Fail. 2026 Aug 10:e014410. doi: 10.1161/CIRCHEARTFAILURE.126.014410.
    

    >> Share

    
    

    
    Circ Res

12. SPANOS M, Gokulnath P, Behera G, Azzam C, et al
    Extracellular Vesicles in Cardiovascular Disease: Intercellular Signaling, Liquid Biopsy Biomarkers, and Therapeutic Translation.
    Circ Res. 2026;139:e327198.
    

    >> Share

    
    

    
    Circulation

13. LIU Y, Chen Y, Zheng H, Li Y, et al
    ABHD11-Mediated mtDNA Transcription Restored Mitochondrial Function to Attenuate Cardiomyocyte Ferroptosis After Myocardial Infarction.
    Circulation. 2026 Aug 11. doi: 10.1161/CIRCULATIONAHA.125.078593.
    

    >> Share

    
    

    
    Clin Cardiol

14. ALAM T, Kamal S, Rajdeep D, Areesha FNU, et al
    Temporal Trends in Mortality Due to Ischemic Heart Disease and Cardiac Arrhythmias in the United States From 1999 to 2023.
    Clin Cardiol. 2026;49:e70450.
    

    >> Share

    
    
15. 
    Correction to "Trends and Disparities in Acute Myocardial Infarction-Related Mortality With Co-Listed Nicotine Dependence in the United States, 1999-2020".
    Clin Cardiol. 2026;49:e70432.
    

    >> Share

    
    
16. MYLAVARAPU M, Samuel J, Thandi R, Mubashir R, et al
    Cardiovascular Disease (CVD) Risk in Women With Endometriosis: A Comprehensive Meta-Analysis.
    Clin Cardiol. 2026;49:e70443.
    

    >> Share

    
    

    
    Eur Heart J

17. WENZL FA, Wang P, Kahles F, Beck KR, et al
    Gut microbiota-derived imidazole propionate predicts cardiometabolic risk in patients with coronary artery disease.
    Eur Heart J. 2025 Aug 30:ehaf661. doi: 10.1093.
    

    >> Share

    
    
18. BHATT DL, Perrone Filardi P, Khan I, Tunon J, et al
    PCSK9 inhibitor treatment and outcomes in patients with atherosclerotic cardiovascular disease but without prior ischaemic events: an observational study.
    Eur Heart J. 2026 Apr 16:ehag176. doi: 10.1093.
    

    >> Share

    
    
19. PARGAONKAR VS, Schnittger I, Wong CCY, Wang H, et al
    Angina with non-obstructive coronary arteries and myocardial bridge: long-term outcomes of surgical unroofing.
    Eur Heart J. 2026;47:4290-4303.
    

    >> Share

    
    
20. CENKO E, Badimon L, Vadala G, Merkus D, et al
    Pathophysiology, prevention, and management of coronary microvascular obstruction.
    Eur Heart J. 2026 May 26:ehag334. doi: 10.1093.
    

    >> Share

    
    
21. LARSEN AF, Kuhl JT, Sigvardsen PE, Afzal S, et al
    Gender-related risk of myocardial infarction and subclinical coronary atherosclerosis: a Danish population cohort study.
    Eur Heart J. 2026 Aug 12:ehag612. doi: 10.1093.
    

    >> Share

    
    

    
    Heart

22. LAU EYM, Abotabekh A, Liu X, Abdelrazik A, et al
    Sudden cardiac death risk after myocardial infarction across the spectrum of left ventricular ejection fraction: a meta-analysis.
    Heart. 2026 Aug 3:heartjnl-2026-327792. doi: 10.1136/heartjnl-2026-327792.
    

    >> Share

    
    

    
    J Am Coll Cardiol

23. ALEXANDER KP, Damluji AA, Erqou S, Ferrucci L, et al
    Cognitive Impairment and Frailty in Older Adults With Cardiovascular Disease: 2026 ACC Scientific Statement: A Report of the American College of Cardiology.
    J Am Coll Cardiol. 2026 Aug 10:S0735-1097(26)07126.
    

    >> Share

    
    
24. DARDARI ZA, Yao Z, Zhang J, Bakoyannis G, et al
    Risk Reclassification Beyond BMI by Waist Circumference and Waist-to-Hip Ratio Across 9 Cardiovascular Outcomes: Results From the Cross-Cohort Collaboration.
    J Am Coll Cardiol. 2026;88:670-684.
    

    >> Share

    
    
25. PATEL KV, Thangada ND
    Tipping the Scale Away From Body Mass Index?: Waist-Based Measures of Adiposity and Cardiovascular Disease Risk.
    J Am Coll Cardiol. 2026;88:685-687.
    

    >> Share

    
    
26. ERHABOR J, Silver N, Blaha MJ
    Cardiovascular Prevention and the Implementation Gap in GLP-1 Receptor Agonist Therapies: After the Trials.
    J Am Coll Cardiol. 2026;88:710-712.
    

    >> Share

    
    
27. O'DONOGHUE ML
    Beyond Short-Term Risk: A New Framework for Cardiovascular Prevention.
    J Am Coll Cardiol. 2026 Jul 28:S0735-1097(26)07185.
    

    >> Share

    
    
28. LIBBY P, Honigberg MC
    Seeking the Sweet Spot in Targeting Cardiovascular Inflammation.
    J Am Coll Cardiol. 2026 Aug 3:S0735-1097(26)07040.
    

    >> Share

    
    
29. HUANG D, Wu H, Lu Y, Liu Q, et al
    Intravenous Nicorandil in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI: The CLEAN Randomized Clinical Trial.
    J Am Coll Cardiol. 2026 Jul 30:S0735-1097(26)07071.
    

    >> Share

    
    

    
    J Cardiovasc Pharmacol

30. YANG J, Meng K, Wu G, Liang J, et al
    Empagliflozin Reduces Post-Myocardial Infarction Inflammation via BDH1/beta-Hydroxybutyrate-Mediated NF-kappaB Modulation in Macrophages and the Heart.
    J Cardiovasc Pharmacol. 2026 Aug 12. doi: 10.1097/FJC.0000000000001870.
    

    >> Share

    
    
31. KIRDEEV A, Burkin K, Vorobev A, Zbirovskaya E, et al
    Machine Learning Models Integrating CYP2C19 Genotypes for Long-Term Risk Prediction and Personalized Antiplatelet Therapy Selection in Myocardial Infarction.
    J Cardiovasc Pharmacol. 2026 Aug 12. doi: 10.1097/FJC.0000000000001871.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

32. MILIOTO A, Ragnarsson O, Ferone D, Adiels M, et al
    Cardiovascular morbidity and mortality in acromegaly-associated diabetes: a Swedish Nationwide study.
    J Clin Endocrinol Metab. 2026 Aug 10:dgag322. doi: 10.1210.
    

    >> Share

    
    

    
    J Nucl Med

33. PACKARD RRS
    2026 SNMMI Highlights Lecture: Cardiovascular Sciences.
    J Nucl Med. 2026 Aug 13:jnumed.126.273334. doi: 10.2967/jnumed.126.273334.
    

    >> Share

    
    

    
    N Engl J Med

34. VAFAI SB, Taubel J, Ashdown T, Patel RS, et al
    In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia.
    N Engl J Med. 2026 May 25. doi: 10.1056/NEJMoa2601283.
    

    >> Share

    
    

    
    PLoS One

35. KIM S, So H, Park HW, Park S, et al
    Association between gallstones and subclinical coronary atherosclerosis: An observational study with propensity score matching.
    PLoS One. 2026;21:e0356142.
    

    >> Share

    
    
36. ABULIMITI F, Fu Z, Huang D, Jureti S, et al
    Trends and projections of IHD burden attributable to dietary high sodium and kidney dysfunction in G20 countries, 1990-2050.
    PLoS One. 2026;21:e0350296.
    

    >> Share

    
    

    
    Prog Cardiovasc Dis

37. INGASON AB, Gregg AC, Redfors B, Gaudino M, et al
    Revascularization options for managing patients with multi-vessel coronary artery disease.
    Prog Cardiovasc Dis. 2026 Aug 12:S0033-0620(26)00076.
    

    >> Share

    
    

    
    Thromb Haemost

38. NA K, Qiu M, Zhang T, Li Y, et al
    Ticagrelor versus Clopidogrel in Acute Coronary Syndrome Patients with High Ischemic and Bleeding Risk after Drug-eluting Stent Implantation.
    Thromb Haemost. 2026 Aug 11. doi: 10.1055/a-2922-8191.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share